The global subcutaneous drug delivery devices market size is expected to reach USD 51.8 billion by 2030, registering to grow at a CAGR of 7.5% from 2024 to 2030 according to a new report. The increasing prevalence of chronic conditions combined with regular medicine administration to relive disease symptoms has enhanced the demand for in-home drug administration devices. As per the Centers for Disease Control and Prevention (CDC), in 2018, about 54.4 million adults, amounting to 22.7% suffered from arthritis, fibromyalgia, gout, or lupus in the U.S. The CDC further stated that by 2040, an estimated 78.0 million adults accounting for 26.0% will be diagnosed with arthritis. ![Subcutaneous Drug Delivery Devices Market]( "Subcutaneous Drug Delivery Devices Market")
In addition, a rising number of biologic medicine approvals for the treatment of life-threatening conditions in patients requiring large dose volumes or extended delivery periods accelerate the demand for subcutaneous drug delivery devices. According to the study published by Informa U.K., in February 2019, the total number of medicines in the clinical trial pipeline increased from 53.0% in 2018 to 55.0% in 2019 for parenteral administrations, with an overall decrease in oral medicine formulations from 33.0% in 2018 to 31.0% in 2019.
In addition, a rising number of biologic medicine approvals for the treatment of life-threatening conditions in patients requiring large dose volumes or extended delivery periods accelerate the demand for subcutaneous drug delivery devices. According to the study published by Informa U.K., in February 2019, the total number of medicines in the clinical trial pipeline increased from 53.0% in 2018 to 55.0% in 2019 for parenteral administrations, with an overall decrease in oral medicine formulations from 33.0% in 2018 to 31.0% in 2019.
Subcutaneous Drug Delivery Devices Market Report Highlights
- North America accounted for the largest revenue share in 2023 owing to the rising prevalence of chronic diseases in the geriatric population and high disposable income
- By product, injection pen is expected to register the highest CAGR during the forecast period owing to ease in providing multi-dose medicine and affordability
- By distribution channel, the retail pharmacies segment accounted for the largest market share as they include large pharmacy chains and attractive schemes and discounts for the novel medicine delivery devices
- Market players are adopting several strategies such as strategic collaborations and product innovations to cater to the increasing patient demand in the global market.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Product
1.2.1.1. Distribution Channel
1.2.1.2. Regional scope
1.2.1.3. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. Internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
1.2. Segment Definitions
1.2.1. Product
1.2.1.1. Distribution Channel
1.2.1.2. Regional scope
1.2.1.3. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. Internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Distribution Channel outlook
2.3. Regional outlook
2.4. Competitive Insights
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Distribution Channel outlook
2.3. Regional outlook
2.4. Competitive Insights
Chapter 3. Subcutaneous Drug Delivery Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising prevalence of chronic diseases
3.2.1.2. Increasing production of biologics
3.2.1.3. Increasing product innovations and approvals
3.2.1.4. Increasing focus on self-administration, prevention of needlestick injuries and dosing errors
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of advanced delivery systems
3.2.2.2. Lack of awareness in developing countries
3.3. Subcutaneous Drug Delivery Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising prevalence of chronic diseases
3.2.1.2. Increasing production of biologics
3.2.1.3. Increasing product innovations and approvals
3.2.1.4. Increasing focus on self-administration, prevention of needlestick injuries and dosing errors
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of advanced delivery systems
3.2.2.2. Lack of awareness in developing countries
3.3. Subcutaneous Drug Delivery Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
Chapter 4. Subcutaneous Drug Delivery Devices Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Subcutaneous Drug Delivery Devices Market: Product Movement Analysis
4.3. Subcutaneous Drug Delivery Devices Market by Product Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Prefilled Syringes
4.5.1. Prefilled Syringes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Pen Injectors
4.6.1. Pen Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Auto Injectors
4.7.1. Auto Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. Wearable Injectors
4.8.1. Wearable Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.9. Needle-free Injectors
4.9.1. Needle-free Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2. Subcutaneous Drug Delivery Devices Market: Product Movement Analysis
4.3. Subcutaneous Drug Delivery Devices Market by Product Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Prefilled Syringes
4.5.1. Prefilled Syringes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Pen Injectors
4.6.1. Pen Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Auto Injectors
4.7.1. Auto Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. Wearable Injectors
4.8.1. Wearable Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.9. Needle-free Injectors
4.9.1. Needle-free Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Subcutaneous Drug Delivery Devices Market: Distribution Channel Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Subcutaneous Drug Delivery Devices Market: Distribution Channel Movement Analysis
5.3. Subcutaneous Drug Delivery Devices Market by Distribution Channel Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Hospital Pharmacies
5.5.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Retail Pharmacies
5.6.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Online Pharmacies
5.7.1. Online Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2. Subcutaneous Drug Delivery Devices Market: Distribution Channel Movement Analysis
5.3. Subcutaneous Drug Delivery Devices Market by Distribution Channel Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Hospital Pharmacies
5.5.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Retail Pharmacies
5.6.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Online Pharmacies
5.7.1. Online Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Subcutaneous Drug Delivery Devices Market: Regional Estimates & Trend Analysis
6.1. Regional Dashboard
6.2. Regional Subcutaneous Drug Delivery Devices Market Movement Analysis
6.3. Subcutaneous Drug Delivery Devices Market: Regional Estimates & Trend Analysis by Distribution Channel & End-use
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. North America
6.5.1. North America Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. U.S.
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Reimbursement scenario
6.5.2.5. U.S. Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. Canada
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. Reimbursement scenario
6.5.3.5. Canada Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.4. Mexico
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Regulatory Framework
6.5.4.4. Reimbursement scenario
6.5.4.5. Mexico Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Europe
6.6.1. Europe Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.2. UK
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. Reimbursement scenario
6.6.2.5. UK Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.3. Germany
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. Reimbursement scenario
6.6.3.5. Germany Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.4. France
6.6.4.1. Key Country Dynamics
6.6.4.2. Competitive Scenario
6.6.4.3. Regulatory Framework
6.6.4.4. Reimbursement scenario
6.6.4.5. France Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.5. Italy
6.6.5.1. Key Country Dynamics
6.6.5.2. Competitive Scenario
6.6.5.3. Regulatory Framework
6.6.5.4. Reimbursement scenario
6.6.5.5. Italy Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.6. Spain
6.6.6.1. Key Country Dynamics
6.6.6.2. Competitive Scenario
6.6.6.3. Regulatory Framework
6.6.6.4. Reimbursement scenario
6.6.6.5. Spain Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.7. Denmark
6.6.7.1. Key Country Dynamics
6.6.7.2. Competitive Scenario
6.6.7.3. Regulatory Framework
6.6.7.4. Reimbursement scenario
6.6.7.5. Denmark Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.8. Sweden
6.6.8.1. Key Country Dynamics
6.6.8.2. Competitive Scenario
6.6.8.3. Regulatory Framework
6.6.8.4. Reimbursement scenario
6.6.8.5. Sweden Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.9. Norway
6.6.9.1. Key Country Dynamics
6.6.9.2. Competitive Scenario
6.6.9.3. Regulatory Framework
6.6.9.4. Reimbursement scenario
6.6.9.5. Norway Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Asia Pacific
6.7.1. Asia Pacific Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.2. Japan
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory Framework
6.7.2.4. Reimbursement scenario
6.7.2.5. Japan Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.3. China
6.7.3.1. Key Country Dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory Framework
6.7.3.4. Reimbursement scenario
6.7.3.5. China Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.4. India
6.7.4.1. Key Country Dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Regulatory Framework
6.7.4.4. Reimbursement scenario
6.7.4.5. India Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.5. South Korea
6.7.5.1. Key Country Dynamics
6.7.5.2. Competitive Scenario
6.7.5.3. Regulatory Framework
6.7.5.4. Reimbursement scenario
6.7.5.5. South Korea Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.6. Australia
6.7.6.1. Key Country Dynamics
6.7.6.2. Competitive Scenario
6.7.6.3. Regulatory Framework
6.7.6.4. Reimbursement scenario
6.7.6.5. Australia Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.7. Thailand
6.7.7.1. Key Country Dynamics
6.7.7.2. Competitive Scenario
6.7.7.3. Regulatory Framework
6.7.7.4. Reimbursement scenario
6.7.7.5. Thailand Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Latin America
6.8.1. Latin America Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.2. Brazil
6.8.2.1. Key Country Dynamics
6.8.2.2. Competitive Scenario
6.8.2.3. Regulatory Framework
6.8.2.4. Reimbursement scenario
6.8.2.5. Brazil Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.3. Argentina
6.8.3.1. Key Country Dynamics
6.8.3.2. Competitive Scenario
6.8.3.3. Regulatory Framework
6.8.3.4. Reimbursement scenario
6.8.3.5. Argentina Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.9. Middle East & Africa
6.9.1. Middle East & Africa Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.9.2. South Africa
6.9.2.1. Key Country Dynamics
6.9.2.2. Competitive Scenario
6.9.2.3. Regulatory Framework
6.9.2.4. Reimbursement scenario
6.9.2.5. South Africa Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.9.3. Saudi Arabia
6.9.3.1. Key Country Dynamics
6.9.3.2. Competitive Scenario
6.9.3.3. Regulatory Framework
6.9.3.4. Reimbursement scenario
6.9.3.5. Saudi Arabia Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.9.4. UAE
6.9.4.1. Key Country Dynamics
6.9.4.2. Competitive Scenario
6.9.4.3. Regulatory Framework
6.9.4.4. Reimbursement scenario
6.9.4.5. UAE Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.9.5. Kuwait
6.9.5.1. Key Country Dynamics
6.9.5.2. Competitive Scenario
6.9.5.3. Regulatory Framework
6.9.5.4. Reimbursement scenario
6.9.5.5. Kuwait Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.2. Regional Subcutaneous Drug Delivery Devices Market Movement Analysis
6.3. Subcutaneous Drug Delivery Devices Market: Regional Estimates & Trend Analysis by Distribution Channel & End-use
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5. North America
6.5.1. North America Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.2. U.S.
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Reimbursement scenario
6.5.2.5. U.S. Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.3. Canada
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. Reimbursement scenario
6.5.3.5. Canada Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5.4. Mexico
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Regulatory Framework
6.5.4.4. Reimbursement scenario
6.5.4.5. Mexico Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Europe
6.6.1. Europe Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.2. UK
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. Reimbursement scenario
6.6.2.5. UK Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.3. Germany
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. Reimbursement scenario
6.6.3.5. Germany Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.4. France
6.6.4.1. Key Country Dynamics
6.6.4.2. Competitive Scenario
6.6.4.3. Regulatory Framework
6.6.4.4. Reimbursement scenario
6.6.4.5. France Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.5. Italy
6.6.5.1. Key Country Dynamics
6.6.5.2. Competitive Scenario
6.6.5.3. Regulatory Framework
6.6.5.4. Reimbursement scenario
6.6.5.5. Italy Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.6. Spain
6.6.6.1. Key Country Dynamics
6.6.6.2. Competitive Scenario
6.6.6.3. Regulatory Framework
6.6.6.4. Reimbursement scenario
6.6.6.5. Spain Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.7. Denmark
6.6.7.1. Key Country Dynamics
6.6.7.2. Competitive Scenario
6.6.7.3. Regulatory Framework
6.6.7.4. Reimbursement scenario
6.6.7.5. Denmark Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.8. Sweden
6.6.8.1. Key Country Dynamics
6.6.8.2. Competitive Scenario
6.6.8.3. Regulatory Framework
6.6.8.4. Reimbursement scenario
6.6.8.5. Sweden Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6.9. Norway
6.6.9.1. Key Country Dynamics
6.6.9.2. Competitive Scenario
6.6.9.3. Regulatory Framework
6.6.9.4. Reimbursement scenario
6.6.9.5. Norway Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Asia Pacific
6.7.1. Asia Pacific Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.2. Japan
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory Framework
6.7.2.4. Reimbursement scenario
6.7.2.5. Japan Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.3. China
6.7.3.1. Key Country Dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory Framework
6.7.3.4. Reimbursement scenario
6.7.3.5. China Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.4. India
6.7.4.1. Key Country Dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Regulatory Framework
6.7.4.4. Reimbursement scenario
6.7.4.5. India Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.5. South Korea
6.7.5.1. Key Country Dynamics
6.7.5.2. Competitive Scenario
6.7.5.3. Regulatory Framework
6.7.5.4. Reimbursement scenario
6.7.5.5. South Korea Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.6. Australia
6.7.6.1. Key Country Dynamics
6.7.6.2. Competitive Scenario
6.7.6.3. Regulatory Framework
6.7.6.4. Reimbursement scenario
6.7.6.5. Australia Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7.7. Thailand
6.7.7.1. Key Country Dynamics
6.7.7.2. Competitive Scenario
6.7.7.3. Regulatory Framework
6.7.7.4. Reimbursement scenario
6.7.7.5. Thailand Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Latin America
6.8.1. Latin America Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.2. Brazil
6.8.2.1. Key Country Dynamics
6.8.2.2. Competitive Scenario
6.8.2.3. Regulatory Framework
6.8.2.4. Reimbursement scenario
6.8.2.5. Brazil Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8.3. Argentina
6.8.3.1. Key Country Dynamics
6.8.3.2. Competitive Scenario
6.8.3.3. Regulatory Framework
6.8.3.4. Reimbursement scenario
6.8.3.5. Argentina Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.9. Middle East & Africa
6.9.1. Middle East & Africa Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.9.2. South Africa
6.9.2.1. Key Country Dynamics
6.9.2.2. Competitive Scenario
6.9.2.3. Regulatory Framework
6.9.2.4. Reimbursement scenario
6.9.2.5. South Africa Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.9.3. Saudi Arabia
6.9.3.1. Key Country Dynamics
6.9.3.2. Competitive Scenario
6.9.3.3. Regulatory Framework
6.9.3.4. Reimbursement scenario
6.9.3.5. Saudi Arabia Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.9.4. UAE
6.9.4.1. Key Country Dynamics
6.9.4.2. Competitive Scenario
6.9.4.3. Regulatory Framework
6.9.4.4. Reimbursement scenario
6.9.4.5. UAE Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.9.5. Kuwait
6.9.5.1. Key Country Dynamics
6.9.5.2. Competitive Scenario
6.9.5.3. Regulatory Framework
6.9.5.4. Reimbursement scenario
6.9.5.5. Kuwait Subcutaneous Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Market Participant Categorization
7.2. Key Company Profiles
7.2.1. Gerresheimer AG
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Medtronic Plc
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Ypsomed AG
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Elcam Medical Group
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Novo Nordisk
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Insulet Corporation
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. Becton, Dickinson and Company
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. West Pharmaceutical Services, Inc.
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. PharmaJet
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. Unilife Corporation
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives
7.2.11. Inolife Sciences
7.2.11.1. Company overview
7.2.11.2. Financial performance
7.2.11.3. Product benchmarking
7.2.11.4. Strategic initiatives
7.2. Key Company Profiles
7.2.1. Gerresheimer AG
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. Medtronic Plc
7.2.2.1. Company overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Ypsomed AG
7.2.3.1. Company overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. Elcam Medical Group
7.2.4.1. Company overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Novo Nordisk
7.2.5.1. Company overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Insulet Corporation
7.2.6.1. Company overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. Becton, Dickinson and Company
7.2.7.1. Company overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. West Pharmaceutical Services, Inc.
7.2.8.1. Company overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. PharmaJet
7.2.9.1. Company overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. Unilife Corporation
7.2.10.1. Company overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives
7.2.11. Inolife Sciences
7.2.11.1. Company overview
7.2.11.2. Financial performance
7.2.11.3. Product benchmarking
7.2.11.4. Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 4 Global subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 5 North America subcutaneous drug delivery devices market, by region, 2018 - 2030 (USD Million)
Table 6 North America subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 7 North America subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 8 U.S. subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 9 U.S. subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 10 Canada subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 11 Canada subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 12 Mexico subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 13 Mexico subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 14 Europe subcutaneous drug delivery devices market, by country, 2018 - 2030 (USD Million)
Table 15 Europe subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 16 Europe subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 17 UK subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 18 UK subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 19 Germany subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 20 Germany subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 21 France subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 22 France subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 23 Italy subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 24 Italy subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 25 Spain subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 26 Spain subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 27 Norway subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 28 Norway subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 29 Sweden subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 30 Sweden subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 31 Denmark subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 32 Denmark subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 33 Asia Pacific subcutaneous drug delivery devices market, by country, 2018 - 2030 (USD Million)
Table 34 Asia Pacific subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 35 Asia Pacific subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 36 Japan subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 37 Japan subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 38 China subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 39 China subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 40 India subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 41 India subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 42 Australia subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 43 Australia subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 44 South Korea subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 45 South Korea subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 46 Thailand subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 47 Thailand subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 48 Latin America subcutaneous drug delivery devices market, by country, 2018 - 2030 (USD Million)
Table 49 Latin America subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 50 Latin America subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 51 Brazil subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 52 Brazil subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 53 Argentina subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 54 Argentina subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 55 Middle East & Africa subcutaneous drug delivery devices market, by country, 2018 - 2030 (USD Million)
Table 56 Middle East & Africa subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 57 Middle East & Africa subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 58 South Africa subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 59 South Africa subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 60 Saudi Arabia subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 61 Saudi Arabia subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 62 UAE subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 63 UAE subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 64 Kuwait subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 65 Kuwait subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 2 List of Abbreviations
Table 3 Global subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 4 Global subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 5 North America subcutaneous drug delivery devices market, by region, 2018 - 2030 (USD Million)
Table 6 North America subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 7 North America subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 8 U.S. subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 9 U.S. subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 10 Canada subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 11 Canada subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 12 Mexico subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 13 Mexico subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 14 Europe subcutaneous drug delivery devices market, by country, 2018 - 2030 (USD Million)
Table 15 Europe subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 16 Europe subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 17 UK subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 18 UK subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 19 Germany subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 20 Germany subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 21 France subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 22 France subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 23 Italy subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 24 Italy subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 25 Spain subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 26 Spain subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 27 Norway subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 28 Norway subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 29 Sweden subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 30 Sweden subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 31 Denmark subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 32 Denmark subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 33 Asia Pacific subcutaneous drug delivery devices market, by country, 2018 - 2030 (USD Million)
Table 34 Asia Pacific subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 35 Asia Pacific subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 36 Japan subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 37 Japan subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 38 China subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 39 China subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 40 India subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 41 India subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 42 Australia subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 43 Australia subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 44 South Korea subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 45 South Korea subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 46 Thailand subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 47 Thailand subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 48 Latin America subcutaneous drug delivery devices market, by country, 2018 - 2030 (USD Million)
Table 49 Latin America subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 50 Latin America subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 51 Brazil subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 52 Brazil subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 53 Argentina subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 54 Argentina subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 55 Middle East & Africa subcutaneous drug delivery devices market, by country, 2018 - 2030 (USD Million)
Table 56 Middle East & Africa subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 57 Middle East & Africa subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 58 South Africa subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 59 South Africa subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 60 Saudi Arabia subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 61 Saudi Arabia subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 62 UAE subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 63 UAE subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
Table 64 Kuwait subcutaneous drug delivery devices market, by product, 2018 - 2030 (USD Million)
Table 65 Kuwait subcutaneous drug delivery devices market, by distribution channel, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Information Procurement
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 Subcutaneous drug delivery devices market segmentation
Fig. 7 Market driver analysis (Current & future impact)
Fig. 8 Market restraint analysis (Current & future impact)
Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 10 Porter’s Five Forces Analysis
Fig. 11 Subcutaneous drug delivery devices market, product outlook key takeaways (USD Million)
Fig. 12 Subcutaneous drug delivery devices market product movement analysis 2023 & 2030 (USD Million)
Fig. 13 Prefilled syringes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 14 Pen injectors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 15 Auto injectors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 16 Wearable injectors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 17 Needle-free injectors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 Subcutaneous drug delivery devices market, distribution channel outlook key takeaways (USD Million)
Fig. 19 Subcutaneous drug delivery devices market, distribution channel movement analysis 2023 & 2030 (USD Million)
Fig. 20 Hospital pharmacies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Retail pharmacies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Online pharmacies market, application outlook key takeaways (USD Million)
Fig. 23 Subcutaneous drug delivery devices market: Regional key takeaways (USD Million)
Fig. 24 Subcutaneous drug delivery devices market regional outlook, 2023 & 2030, USD Million
Fig. 25 North America subcutaneous drug delivery devices estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 US subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Canada subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Mexico subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Europe subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 UK subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Germany subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 France subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Spain subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Italy subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Sweden subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Norway subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Denmark subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Asia Pacific subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 China subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Japan subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 India subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 South Korea subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Australia subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Thailand subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Latin America subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Brazil subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Argentina subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Middle East and Africa subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 South Africa subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Saudi Arabia subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 UAE subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Kuwait subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 List of key emerging company’s/distribution channel disruptors/innovators
Fig. 2 Primary Research Pattern
Fig. 3 Market Research Approaches
Fig. 4 Value Chain-Based Sizing & Forecasting
Fig. 5 Market Formulation & Validation
Fig. 6 Subcutaneous drug delivery devices market segmentation
Fig. 7 Market driver analysis (Current & future impact)
Fig. 8 Market restraint analysis (Current & future impact)
Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Fig. 10 Porter’s Five Forces Analysis
Fig. 11 Subcutaneous drug delivery devices market, product outlook key takeaways (USD Million)
Fig. 12 Subcutaneous drug delivery devices market product movement analysis 2023 & 2030 (USD Million)
Fig. 13 Prefilled syringes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 14 Pen injectors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 15 Auto injectors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 16 Wearable injectors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 17 Needle-free injectors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 Subcutaneous drug delivery devices market, distribution channel outlook key takeaways (USD Million)
Fig. 19 Subcutaneous drug delivery devices market, distribution channel movement analysis 2023 & 2030 (USD Million)
Fig. 20 Hospital pharmacies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Retail pharmacies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Online pharmacies market, application outlook key takeaways (USD Million)
Fig. 23 Subcutaneous drug delivery devices market: Regional key takeaways (USD Million)
Fig. 24 Subcutaneous drug delivery devices market regional outlook, 2023 & 2030, USD Million
Fig. 25 North America subcutaneous drug delivery devices estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 US subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Canada subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Mexico subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Europe subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 UK subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Germany subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 France subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Spain subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Italy subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Sweden subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Norway subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Denmark subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Asia Pacific subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 China subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Japan subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 India subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 South Korea subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Australia subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Thailand subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Latin America subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Brazil subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Argentina subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Middle East and Africa subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 South Africa subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Saudi Arabia subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 UAE subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Kuwait subcutaneous drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 List of key emerging company’s/distribution channel disruptors/innovators
Companies Mentioned
- Gerresheimer AG
- Medtronic Plc
- Ypsomed AG
- Elcam Medical Group
- Novo Nordisk
- Insulet Corporation
- Becton, Dickinson and Company
- West Pharmaceutical Services, Inc.
- PharmaJet
- Unilife Corporation
- Inolife Sciences
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 130 |
| Published | July 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 31.2 Billion |
| Forecasted Market Value ( USD | $ 51.8 Billion |
| Compound Annual Growth Rate | 7.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
![Subcutaneous Drug Delivery Device Market: Trends, Opportunities and Competitive Analysis [2023-2028] - Product Image](http://www.researchandmarkets.com/product_images/12488/12488556_60px_jpg/subcutaneous_drug_delivery_device_market.jpg)
